Jeffrey Zekaukas
Stock Analyst at JP Morgan
(1.58)
# 3,430
Out of 4,996 analysts
26
Total ratings
40%
Success rate
-1.42%
Average return
Main Sectors:
Stocks Rated by Jeffrey Zekaukas
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MOS The Mosaic Company | Maintains: Overweight | $35 → $37 | $35.32 | +4.76% | 6 | Aug 11, 2025 | |
EMN Eastman Chemical Company | Downgrades: Neutral | $112 → $76 | $62.71 | +21.19% | 8 | Apr 28, 2025 | |
ECL Ecolab | Downgrades: Neutral | $200 → $220 | $271.00 | -18.82% | 5 | Feb 14, 2024 | |
LYB LyondellBasell Industries | Upgrades: Overweight | $95 → $100 | $49.45 | +102.22% | 3 | Feb 5, 2024 | |
AVY Avery Dennison | Maintains: Overweight | $185 → $218 | $160.75 | +35.61% | 2 | Feb 1, 2024 | |
LLY Eli Lilly and Company | Maintains: Equal-Weight | $148 → $157 | $724.54 | -78.33% | 2 | Aug 14, 2020 |
The Mosaic Company
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $37
Current: $35.32
Upside: +4.76%
Eastman Chemical Company
Apr 28, 2025
Downgrades: Neutral
Price Target: $112 → $76
Current: $62.71
Upside: +21.19%
Ecolab
Feb 14, 2024
Downgrades: Neutral
Price Target: $200 → $220
Current: $271.00
Upside: -18.82%
LyondellBasell Industries
Feb 5, 2024
Upgrades: Overweight
Price Target: $95 → $100
Current: $49.45
Upside: +102.22%
Avery Dennison
Feb 1, 2024
Maintains: Overweight
Price Target: $185 → $218
Current: $160.75
Upside: +35.61%
Eli Lilly and Company
Aug 14, 2020
Maintains: Equal-Weight
Price Target: $148 → $157
Current: $724.54
Upside: -78.33%